Rarity IDH1/IDH2 Panel for Acute Myeloid Leukemia

The SuperRCA technology was first developed together with hematologists to aid in ultrasensitive detection of rare mutations in leukemic variants, such as Acute Myeloid Leukemia (AML). We are therefore happy to announce that our first version of the Rarity AML panel is now available for research service testing, covering the relevant mutations for targeted treatment […]